EP2061493A4 - Compositions to reduce or prevent skin cancer - Google Patents

Compositions to reduce or prevent skin cancer

Info

Publication number: EP2061493A4
Authority: EP; European Patent Office
Prior art keywords: compositions; reduce; skin cancer; prevent skin; prevent
Prior art date: 2006-08-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP06789889A

Other languages

German (de)

French (fr)

Other versions

EP2061493A1 (en

Inventor

Zoltan Kiss

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Essential SkinCare LLC

Original Assignee

Essential SkinCare LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-21

Filing date

2006-08-21

Publication date

2011-01-12

2006-08-21 Application filed by Essential SkinCare LLC filed Critical Essential SkinCare LLC

2009-05-27 Publication of EP2061493A1 publication Critical patent/EP2061493A1/en

2011-01-12 Publication of EP2061493A4 publication Critical patent/EP2061493A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03001—Alkaline phosphatase (3.1.3.1)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Inorganic Chemistry (AREA)
Wood Science & Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP06789889A 2006-08-21 2006-08-21 Compositions to reduce or prevent skin cancer Withdrawn EP2061493A4 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2006/032549 WO2008024103A1 (en)	2006-08-21	2006-08-21	Compositions to reduce or prevent skin cancer

Publications (2)

Publication Number	Publication Date
EP2061493A1 EP2061493A1 (en)	2009-05-27
EP2061493A4 true EP2061493A4 (en)	2011-01-12

Family

ID=39107080

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP06789889A Withdrawn EP2061493A4 (en)	2006-08-21	2006-08-21	Compositions to reduce or prevent skin cancer

Country Status (2)

Country	Link
EP (1)	EP2061493A4 (en)
WO (1)	WO2008024103A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3345614A1 (en) *	2017-01-05	2018-07-11	Amrif B.V.	Composition comprising alkaline phosphatase for use in the treatment of arthritides
CA3057089A1 (en)	2017-03-21	2018-09-27	Synthetic Biologics, Inc.	Alkaline phosphatase formulations
EP3737750B1 (en)	2018-01-09	2024-06-05	Theriva Biologics, Inc.	Alkaline phosphatase agents for treatment of neurodevelopmental disorders
WO2019183208A1 (en)	2018-03-20	2019-09-26	Synthetic Biologics, Inc.	Intestinal alkaline phosphatase formulations
CA3094174A1 (en)	2018-03-20	2019-09-26	Synthetic Biologics, Inc.	Alkaline phosphatase agents for treatment of radiation disorders

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0302473A2 (en) *	1987-08-04	1989-02-08	Bristol-Myers Squibb Company	Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
US20020177583A1 (en) *	2001-03-29	2002-11-28	Zoltan Kiss	Methods and compositions for the treatment of human and animal cancers
WO2007075199A1 (en) *	2005-12-28	2007-07-05	Zoltan Laboratories Llc	Use of alkaline phosphatase to maintain healthy tissue mass in mammals

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7374754B2 (en) *	2003-09-02	2008-05-20	Essential Skincare, Llc	Use of placental alkaline phosphatase to promote skin cell proliferation

2006
- 2006-08-21 EP EP06789889A patent/EP2061493A4/en not_active Withdrawn
- 2006-08-21 WO PCT/US2006/032549 patent/WO2008024103A1/en active Application Filing

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0302473A2 (en) *	1987-08-04	1989-02-08	Bristol-Myers Squibb Company	Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
US20020177583A1 (en) *	2001-03-29	2002-11-28	Zoltan Kiss	Methods and compositions for the treatment of human and animal cancers
WO2007075199A1 (en) *	2005-12-28	2007-07-05	Zoltan Laboratories Llc	Use of alkaline phosphatase to maintain healthy tissue mass in mammals

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2008024103A1 *

Also Published As

Publication number	Publication date
WO2008024103A1 (en)	2008-02-28
EP2061493A1 (en)	2009-05-27

Publication	Publication Date	Title
HRP20160949T1 (en)	2016-10-07	Novel compositions and methods for cancer treatment
GB0719161D0 (en)	2007-11-07	Improvements relating to fabrick treatment compositions
AP2008004713A0 (en)	2008-12-31	Improvements relating to anti-parasetic compositions
EP2116224A4 (en)	2013-01-02	Cosmetic composition
EP2365815A4 (en)	2016-11-30	Extracellular matrix compositions for the treatment of cancer
EP1996612A4 (en)	2010-10-20	Compositions for treatment of cancer
PL2059223T3 (en)	2013-03-29	Skin care composition
IL200251A0 (en)	2010-04-29	Compositions and methods to prevent cancer with cupredoxins
GB0601644D0 (en)	2006-03-08	Antiperspirant compositions
IL197602A0 (en)	2011-08-01	Compositions and methods to prevent cancer with cupredoxins
IL197235A0 (en)	2009-12-24	Therapeutic compositions
EP2209458A4 (en)	2014-08-13	Skin treatment compositions
IL238394B (en)	2018-05-31	Compositions comprising combination of agents for cancer treatment
EP1986682A4 (en)	2010-03-03	Methods and compositions related to targeting tumors and wounds
GB0702931D0 (en)	2007-03-28	Skin application
EP1979487A4 (en)	2010-05-05	Cobalamin compositions for the treatment of cancer
HK1129601A1 (en)	2009-12-04	Compositions for contributing to the treatment of cancers
EP2039340A4 (en)	2013-12-04	Skin cleansing composition
GB0908728D0 (en)	2009-07-01	Skin cleansing compositions
EP2061493A4 (en)	2011-01-12	Compositions to reduce or prevent skin cancer
HK1138508A1 (en)	2010-08-27	Composition for external application to skin
GB0622847D0 (en)	2006-12-27	Cosmetic composition
EP2221040A4 (en)	2015-07-22	Composition for external application to skin
EP2056839A4 (en)	2009-09-09	Combination approaches to cancer treatment
HK1137331A1 (en)	2010-07-30	Composition for external application to skin

Legal Events

Date	Code	Title	Description
2009-04-24	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2009-05-27	17P	Request for examination filed	Effective date: 20090320
2009-05-27	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2009-05-27	AX	Request for extension of the european patent	Extension state: AL BA HR MK RS
2011-01-12	A4	Supplementary search report drawn up and despatched	Effective date: 20101213
2011-01-12	RIC1	Information provided on ipc code assigned before grant	Ipc: A61P 35/00 20060101ALI20101207BHEP Ipc: A61K 38/57 20060101ALI20101207BHEP Ipc: A61K 38/46 20060101ALI20101207BHEP Ipc: A61K 38/16 20060101AFI20080403BHEP
2011-09-28	17Q	First examination report despatched	Effective date: 20110830
2012-07-25	DAX	Request for extension of the european patent (deleted)
2013-06-14	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN
2013-07-17	18W	Application withdrawn	Effective date: 20130603